why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: March 28, 2025

Clinical Trial: A Study to Assess New Formulations of TEV-56286

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Randomized, Crossover Study to Assess the Comparative Bioavailability of New TEV-56286 Formulations Compared to a Reference TEV-56286 Capsule Formulation Following Single-Dose Administr

Brief Summary: The primary objective of the study is to assess the relative bioavailability of TEV-56286 test formulations compared to TEV-56286 reference product in healthy adult participants.The secondary objective is to evaluate the safety and tolerability of TEV-56286.The planned duration for each participant is approximately 70 days which includes a 45 day screening period.

Read more